Exodus Point Capital Management, LP Pmv Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$6.01 - $8.93 $229,810 - $341,465	38,238 New	38,238 $235,000
Q1 2023 May 11, 2023	BUY	$4.77 - $9.16 $1,249 - $2,399	262 Added 1.7%	15,698 $75,000
Q4 2022 Feb 13, 2023	SELL	$8.17 - $12.95 $145,581 - $230,756	-17,819 Reduced 53.58%	15,436 $134,000
Q3 2022 Nov 10, 2022	BUY	$11.4 - $17.18 $379,107 - $571,320	33,255 New	33,255 $396,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.